Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonidegib in Chinese adults with locally advanced basal cell carcinoma
CTR20222668Phase 4Completed
- Sponsor
- Sun Pharma
- Start
- Jun 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sonidegib in basal cell carcinoma (BCC), sponsored by Sun Pharma. Started Jun 2023; status: completed.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on CTR20222668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222668.